Cargando…

Tumor Necrosis Factor-α, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects

BACKGROUND: Type 1 diabetes (T1D) is an autoimmune disease resulting in the targeted destruction of pancreatic β-cells and permanent loss of insulin production. Proper glucose management results in better clinical outcomes for T1D and provides a strong rationale to identify non-invasive biomarkers i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuehl, Melanie N., Rodriguez, Henry, Burkhardt, Brant R., Alman, Amy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411091/ https://www.ncbi.nlm.nih.gov/pubmed/25915398 http://dx.doi.org/10.1371/journal.pone.0125320

Ejemplares similares

Circulating PANDER concentration is associated with increased HbA1c and fasting blood glucose in Type 2 diabetic subjects
por: MarElia, Catherine B., et al.
Publicado: (2018)

Linking the oral microbiome and salivary cytokine abundance to circadian oscillations
por: Sarkar, Anujit, et al.
Publicado: (2021)

Matrix metalloproteinases in subjects with type 1 diabetes
por: Gharagozlian, Sedegheh, et al.
Publicado: (2009)

Gene Polymorphism of Matrix Metalloproteinase 9 in Asthenozoospermic Male Subjects
por: Mohagheghi, Sina, et al.
Publicado: (2018)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Matrix metalloproteinase-9 predicts pulmonary status declines in α(1)-antitrypsin deficiency
por: Omachi, Theodore A, et al.
Publicado: (2011)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer
por: Chang, Ya-Ting, et al.
Publicado: (2020)

Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1
por: Zhou, Ling, et al.
Publicado: (2009)

Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-α
por: Marquez-Curtis, Leah A., et al.
Publicado: (2012)

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood
por: Madjid, Tita Husnitawati, et al.
Publicado: (2020)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Elastase and metalloproteinase-9 concentrations in saliva in patients with chronic periodontitis
por: Nędzi-Góra, Małgorzata, et al.
Publicado: (2014)

Elastase and metalloproteinase 9 concentrations in saliva in patients with chronic periodontitis
por: Nędzi-Góra, M, et al.
Publicado: (2016)

Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-α in Chronic Hepatitis C Virus Patients
por: Abdel-Latif, Mohamed S
Publicado: (2015)

The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
por: Mroczko, Barbara, et al.
Publicado: (2010)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations☆
por: Di, Fei, et al.
Publicado: (2012)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients
por: Lubis, Bastian, et al.
Publicado: (2022)

Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts
por: Chellaiah, Meenakshi A., et al.
Publicado: (2013)

Associations of Dietary Patterns and Nutrients with Glycated Hemoglobin in Participants with and without Type 1 Diabetes
por: Basu, Arpita, et al.
Publicado: (2021)

Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium
por: KÜÇÜKAYDIN, Zehra, et al.
Publicado: (2022)

Effects of resveratrol and genistein on nuclear factor-κB, tumor necrosis factor-α and matrix metalloproteinase-9 in patients with chronic obstructive pulmonary disease
por: LIU, XIAO-JU, et al.
Publicado: (2016)

Mangiferin inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-κB activity
por: Dilshara, Matharage Gayani, et al.
Publicado: (2015)

Usefulness of matrix metalloproteinase-7 in saliva as a diagnostic biomarker for laryngopharyngeal reflux disease
por: Im, Nu-Ri, et al.
Publicado: (2021)

Associations of Dietary Antioxidants with Glycated Hemoglobin and Insulin Sensitivity in Adults with and without Type 1 Diabetes
por: Basu, Arpita, et al.
Publicado: (2022)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9
por: Wang, Caimei, et al.
Publicado: (2022)

An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients
por: Demir, Nazlim Aktug, et al.
Publicado: (2023)

Association between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients with Breast Cancer
por: Abdollahi, Alireza, et al.
Publicado: (2019)

Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma
por: DI CARLO, ANGELINA
Publicado: (2014)

Matrix Metalloproteinases -8 and -9 and Tissue Inhibitor of Metalloproteinase-1 in Burn Patients. A Prospective Observational Study
por: Hästbacka, Johanna, et al.
Publicado: (2015)

Effects of Surgery Combined with Different Chemotherapy on Matrix Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-1 in Children with Neuroblastoma
por: Qi, Zilong, et al.
Publicado: (2022)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q06dfmg03vm04j0mu4g9m52m1q